TY - JOUR
T1 - De novo missense mutations in NALCN cause developmental and intellectual impairment with hypotonia
AU - Fukai, Ryoko
AU - Saitsu, Hirotomo
AU - Okamoto, Nobuhiko
AU - Sakai, Yasunari
AU - Fattal-Valevski, Aviva
AU - Masaaki, Shiina
AU - Kitai, Yukihiro
AU - Torio, Michiko
AU - Kojima-Ishii, Kanako
AU - Ihara, Kenji
AU - Chernuha, Veronika
AU - Nakashima, Mitsuko
AU - Miyatake, Satoko
AU - Tanaka, Fumiaki
AU - Miyake, Noriko
AU - Matsumoto, Naomichi
N1 - Publisher Copyright:
© 2016 The Japan Society of Human Genetics.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - Three recessive mutations in the sodium leak channel, nonselective (NALCN) have been reported to cause intellectual disability and hypotonia. In addition, 14 de novo heterozygous mutations have been identified in 15 patients with arthrogryposis and neurodevelopmental impairment. Here, we report three patients with neurodevelopmental disease and hypotonia, harboring one recurrent (p.R1181Q) and two novel mutations (p.L312V and p.V1020F) occurring de novo in NALCN. Mutation p.L312 is located in the pore forming S6 region of domain I and p.V1020F in the S5 region of domain III. Mutation p.R1181Q is in a linker region. Mapping these three mutations to a model of NALCN showed p.Leu312 and p.Val1020 positioned in the hydrophobic core of the pore modules, indicating these two mutations may affect the gating function of NALCN. Although p.R1181Q is unlikely to affect the ion channel structure, previous studies have shown that an analogous mutation in Caenorhabditis elegans produced a phenotype with a coiling locomotion, suggesting that p.R1181Q could also affect NALCN function. Our three patients showed profound intellectual disability and growth delay, facial dysmorphologies and hypotonia. The present data support previous work suggesting heterozygous NALCN mutations lead to syndromic neurodevelopmental impairment.
AB - Three recessive mutations in the sodium leak channel, nonselective (NALCN) have been reported to cause intellectual disability and hypotonia. In addition, 14 de novo heterozygous mutations have been identified in 15 patients with arthrogryposis and neurodevelopmental impairment. Here, we report three patients with neurodevelopmental disease and hypotonia, harboring one recurrent (p.R1181Q) and two novel mutations (p.L312V and p.V1020F) occurring de novo in NALCN. Mutation p.L312 is located in the pore forming S6 region of domain I and p.V1020F in the S5 region of domain III. Mutation p.R1181Q is in a linker region. Mapping these three mutations to a model of NALCN showed p.Leu312 and p.Val1020 positioned in the hydrophobic core of the pore modules, indicating these two mutations may affect the gating function of NALCN. Although p.R1181Q is unlikely to affect the ion channel structure, previous studies have shown that an analogous mutation in Caenorhabditis elegans produced a phenotype with a coiling locomotion, suggesting that p.R1181Q could also affect NALCN function. Our three patients showed profound intellectual disability and growth delay, facial dysmorphologies and hypotonia. The present data support previous work suggesting heterozygous NALCN mutations lead to syndromic neurodevelopmental impairment.
UR - http://www.scopus.com/inward/record.url?scp=84971280882&partnerID=8YFLogxK
U2 - 10.1038/jhg.2015.163
DO - 10.1038/jhg.2015.163
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26763878
AN - SCOPUS:84971280882
SN - 1434-5161
VL - 61
SP - 451
EP - 455
JO - Journal of Human Genetics
JF - Journal of Human Genetics
IS - 5
ER -